MQS Management’s LeMaitre Vascular LMAT Stock Holding History

MQS Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,665	Closed	-$297K	–	499
2025 Q4	$297K	Buy	+3,665	New	+$316K	0.18%	251

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

MQS Management's LMAT Position: Q1 2026 in Review

MQS Management sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 3,665 shares — an estimated $297K sold.

MQS Management first reported a position in LMAT in Q4 2025 and held it in 1 quarter. The position peaked at $297K in Q4 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

MQS Management reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
MQS Management sold 3,665 LeMaitre Vascular shares in Q1 2026, an estimated $297K.
MQS Management first reported a position in LeMaitre Vascular in Q4 2025 and held it in 1 quarter.
MQS Management's LeMaitre Vascular position peaked at $297K in Q4 2025.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on MQS Management's 13F filing for Q1 2026, filed 23 Apr 2026.